🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vittorio Pengo

University of Padua

ORCID: 0000-0003-2064-6071

Also affiliated with PENTA Foundation, ANT Foundation Italy Onlus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.9Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Arthritis Care & Research(2020)10.1002/acr.24468
Top 10%
2.2DataRank
Top 10%84 citations

Diane Zisa, Danieli Andrade, Savino Sciascia, Vittorio Pengo, Maria G. Tektonidou +23 more

Papers

Driven by 12 papers — median percentile 84. Top paper: “Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository”.

Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

Arthritis Care & Research(2020)10.1002/acr.24468
Top 10%
2.2DataRank
Top 10%84 citations

Diane Zisa, Danieli Andrade, Savino Sciascia, Vittorio Pengo, Maria G. Tektonidou +23 more

Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)

Lupus Science & Medicine(2022)10.1136/lupus-2021-000633
Top 16%
1.3DataRank
Top 16%41 citations

Ecem Sevim, Guilherme Ramires de Jesús, Ricard Cervera, Lanlan Ji, Vittorio Pengo +14 more

The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome

Journal of Biological Chemistry(2020)10.1074/jbc.ra120.013939
N/A
0.934DataRank · unranked
39 citations

William Planer, Mathivanan Chinnaraj, Zhiwei Chen, Xiaobing Zuo, Vittorio Pengo +7 more

Cryo-EM structure and functional basis of prothrombin recognition by a type I antiprothrombin antiphospholipid antibody

Blood(2024)10.1182/blood.2023022942
N/A
0.508DataRank · unranked
12 citations

Brock Summers, Katherine Basore, Vittorio Pengo, Robert Flaumenhaft, Nicola Pozzi +1 more

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lara D. Veeken(2024)10.1093/rheumatology/keae583
Top 39%
0.487DataRank
Top 39%8 citations

Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Maria G. Tektonidou +23 more

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository

The Journal of Rheumatology(2020)10.3899/jrheum.200513
N/A
0.477DataRank · unranked
23 citations

Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia +23 more

Lupus anticoagulant and antiprothrombin antibodies: embracing the future

Journal of Thrombosis and Haemostasis(2025)10.1016/j.jtha.2025.03.029
N/A
0.396DataRank · unranked
13 citations

Nicola Pozzi, Vittorio Pengo

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Laboratory Investigation(2023)10.1016/j.labinv.2023.100147
N/A
0.312DataRank · unranked
7 citations

Rohan Willis, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza +67 more

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Lara D. Veeken(2023)10.1093/rheumatology/kead292
N/A
0DataRank · unranked
18 citations

Yasaman Ahmadzadeh, Maria G. Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte +64 more

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2022.10.008
N/A
0DataRank · unranked
159 citations

Antoine Bejjani, Gregory Piazza, David Jiménez, Manuel Monréal, Saurav Chatterjee +13 more

Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance

Journal of Thrombosis and Haemostasis(2024)10.1016/j.jtha.2024.07.005
N/A
0DataRank · unranked
6 citations

Elena Pontara, Suresh Kumar, Vittorio Pengo, Nicola Pozzi

X-ray and solution structures of human beta-2 glycoprotein I reveal a new mechanism of autoantibody recognition

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.25.963314
N/A
0DataRank · unranked
0 citations

William Planer, Mathivanan Chinnaraj, Zhiwei Chen, Xiaobing Zuo, Vittorio Pengo +7 more